Meissa is a private biotech company focused on the advancement of vaccines for respiratory viruses. Meissa was founded on proprietary technologies employing reverse genetics for rational design of more effective live attenuated vaccines. The technology is exclusively licensed from Emory University and Children’s Healthcare of Atlanta. Dr. Moore, together with Dr. Roderick Tang, a vaccine biotech expert, co-founded Meissa. They are supported by a team with extensive experience in all aspects of vaccine development. Meissa is currently a resident company at the Johnson & Johnson Innovation – JLABS in South San Francisco.
| Website | http://www.meissavaccines.com/ |
| Revenue | $7.8 million |
| Employees | 4 (4 on RocketReach) |
| Founded | 2014 |
| Address | 1100 Island Dr Ste 202, Redwood City, California 94065, US |
| Phone | (650) 787-8813 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+11 more
(view full list)
|
| Industry | Biotechnology Research, Drug Stores & Pharmacies, Biotechnology, Retail, Science and Engineering |
| Competitors | Pfizer, AstraZeneca, Johnson & Johnson, Sanofi, Regeneron, GSK, CureVac, Novavax, Moderna Therapeutics, Merck AH +37 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 325414 Companies, NAICS Code 32 Companies |
Looking for a particular Meissa Vaccines employee's phone or email?
Meissa Vaccines Questions
The Meissa Vaccines annual revenue was $7.8 million in 2026.
Xing Cheng is the Associate Director of Virology of Meissa Vaccines.
4 people are employed at Meissa Vaccines.
Meissa Vaccines is based in Redwood City, California.
The NAICS codes for Meissa Vaccines are [3254, 32541, 325, 325414, 32].
The SIC codes for Meissa Vaccines are [283, 28].
Top Meissa Vaccines Employees
-
Xing Cheng
Associate Director of Virology at Meissa Vaccines
Sunnyvale, CA, US15 -
Keith W.
Chief Manufacturing Officer at Meissa Vaccines
Franklin, MA, US11
Related Companies
